Adeno associated viral-mediated intraosseous labeling of bone marrow derived cells for CNS tracking

Maj-Linda B Selenica1, Patrick Reid2, Gabriela Pena2

  • 1Dept of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL, USA.

Insights

Researchers developed a method to label bone marrow derived cells (BMDCs) using viral vectors for tracking in neuroinflammation. This technique allows monitoring of BMDCs

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Neuroinflammation, including microglial activation, is central to neurodegenerative diseases.
  • Bone marrow derived cells (BMDCs) and macrophages are implicated in brain repair and injury responses.
  • Targeting BMDCs offers potential for neuroprotection and gene therapy in CNS disorders.

Purpose of the Study:

  • To develop and validate a method for labeling endogenous BMDCs using viral vectors for tracking in vivo.
  • To assess the efficiency of recombinant adeno-associated virus (rAAV) and lentivirus for gene delivery to mouse bone marrow cells.
  • To investigate the migration of labeled BMDCs into the brain parenchyma under neuroinflammatory conditions.

Main Methods:

  • Intraosseous impregnation of mouse bone marrow with rAAV serotype 9 (rAAV-9) or lentivirus carrying the green fluorescence protein (GFP) gene.
  • Flow cytometry analysis to quantify GFP expression in transduced BMDCs and confirm myeloid origin (CD11b marker).
  • Induction of neuroinflammation using viral mediated overexpression of CCL2 or intracranial LPS injection to assess BMDC extravasation into the CNS.

Main Results:

  • Both rAAV-9 and lentivirus efficiently transduced mouse BMDCs in vivo, with rAAV-9 showing higher transduction efficiency (11.2% vs. 6.8%).
  • GFP-labeled cells were confirmed to be of myeloid origin.
  • Neuroinflammatory stimuli (CCL2 or LPS) significantly recruited GFP-labeled BMDCs from the periphery into the mouse brain parenchyma.

Conclusions:

  • Viral transduction provides an effective method for labeling endogenous BMDCs.
  • This labeling technique enables tracking of BMDCs in the CNS following neuroinflammatory insults.
  • The method holds promise for tracking cell migration and potentially delivering therapeutic genes in neuroinflammatory conditions.

Related Concept Videos